Embla Medical hf. (CPH:EMBLA)
Denmark flag Denmark · Delayed Price · Currency is DKK
27.00
-0.05 (-0.18%)
Oct 30, 2026, 4:59 PM CET

Embla Medical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
94.2283.3468.2858.3942.5163.99
Depreciation & Amortization
52.954.7249.443.3343.4945.54
Other Amortization
10.735.96.586.595.875.99
Asset Writedown & Restructuring Costs
-----0.12
Other Operating Activities
-14.59-5.612.37-2.88-11.826.5
Change in Accounts Receivable
-12.87-12.32-5.52-16.37-13.2-13.18
Change in Inventory
0.32-8.59-5.93-2.27-28.62-15.78
Change in Accounts Payable
1.9411.33-2.2814.910.947.76
Change in Other Net Operating Assets
1.343.863.17-7.3711.58-0.4
Operating Cash Flow
133.99132.62116.0794.3260.77100.53
Operating Cash Flow Growth
7.90%14.26%23.05%55.21%-39.55%8.99%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-11.43-22.07-27.03-29.23-16.55-16.96
Cash Acquisitions
-30.06-14.69-70.07-11.9-41.78-33.94
Sale (Purchase) of Intangibles
-14.56-10.26-12.19-13.05-9.4-9.73
Other Investing Activities
-2.860.94.53-2.971.471.18
Investing Cash Flow
-58.9-46.13-104.77-57.15-66.26-59.45

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-57.4639.79-101.421.69
Long-Term Debt Repaid
--117.33-24.38-40.2-87.06-51.44
Lease Payments
-29.71-27.5-24.38-25.42-21.26-20.05
Net Debt Issued (Repaid)
-87.58-59.8715.41-40.214.36-49.74
Repurchase of Common Stock
-13.71-9.75---9.94-
Other Financing Activities
-0.33-5.16-9.65-0.76-0.63-1.33
Financing Cash Flow
-101.61-74.785.76-40.963.79-51.07

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.454.63-3.55-0.2-6.86-7.18
Miscellaneous Cash Flow Adjustments
---0--0-
Net Cash Flow
-26.0716.3413.51-3.98-8.57-17.17

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
122.56110.5589.0365.0944.2283.57
Free Cash Flow Growth
17.74%24.16%36.78%47.19%-47.08%6.50%
Free Cash Flow Margin
12.29%11.90%10.42%8.29%6.15%11.63%
Free Cash Flow Per Share
0.290.260.210.150.110.20
Levered Free Cash Flow
87.93108.4769.4724.4852.479.11
Unlevered Free Cash Flow
99.41120.678435.759.485.23
Free Cash Flow After Leases
92.8583.0564.6539.6722.9663.53

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
19.3820.5524.0816.0513.1112.15
Cash Income Tax Paid
33.5926.623.4920.3519.6616.3
Change in Working Capital
-9.26-5.73-10.56-11.11-19.29-21.61